Medezine Limited - Period Ending 2019-09-30

Medezine Limited - Period Ending 2019-09-30


Medezine Limited 02349827 false 2018-10-01 2019-09-30 2019-09-30 The principal activity of the company is manufacture of medical appliances. Digita Accounts Production Advanced 6.24.8820.0 Software true false 02349827 2018-10-01 2019-09-30 02349827 2019-09-30 02349827 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2019-09-30 02349827 bus:OrdinaryShareClass2 bus:Non-cumulativeShares 2019-09-30 02349827 bus:OrdinaryShareClass3 bus:Non-cumulativeShares 2019-09-30 02349827 bus:OrdinaryShareClass4 bus:Non-cumulativeShares 2019-09-30 02349827 core:RetainedEarningsAccumulatedLosses 2019-09-30 02349827 core:ShareCapital 2019-09-30 02349827 core:SharePremium 2019-09-30 02349827 core:CurrentFinancialInstruments 2019-09-30 02349827 core:CurrentFinancialInstruments core:WithinOneYear 2019-09-30 02349827 core:Non-currentFinancialInstruments 2019-09-30 02349827 core:Non-currentFinancialInstruments core:AfterOneYear 2019-09-30 02349827 core:FurnitureFittings 2019-09-30 02349827 core:LandBuildings core:ShortLeaseholdAssets 2019-09-30 02349827 core:OfficeEquipment 2019-09-30 02349827 bus:SmallEntities 2018-10-01 2019-09-30 02349827 bus:AuditExemptWithAccountantsReport 2018-10-01 2019-09-30 02349827 bus:FullAccounts 2018-10-01 2019-09-30 02349827 bus:SmallCompaniesRegimeForAccounts 2018-10-01 2019-09-30 02349827 bus:RegisteredOffice 2018-10-01 2019-09-30 02349827 bus:Director1 2018-10-01 2019-09-30 02349827 bus:Director2 2018-10-01 2019-09-30 02349827 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2018-10-01 2019-09-30 02349827 bus:OrdinaryShareClass2 bus:Non-cumulativeShares 2018-10-01 2019-09-30 02349827 bus:OrdinaryShareClass3 bus:Non-cumulativeShares 2018-10-01 2019-09-30 02349827 bus:OrdinaryShareClass4 bus:Non-cumulativeShares 2018-10-01 2019-09-30 02349827 bus:PrivateLimitedCompanyLtd 2018-10-01 2019-09-30 02349827 core:ComputerEquipment 2018-10-01 2019-09-30 02349827 core:FurnitureFittings 2018-10-01 2019-09-30 02349827 core:LandBuildings core:ShortLeaseholdAssets 2018-10-01 2019-09-30 02349827 core:LeaseholdImprovements 2018-10-01 2019-09-30 02349827 core:OfficeEquipment 2018-10-01 2019-09-30 02349827 1 2018-10-01 2019-09-30 02349827 countries:AllCountries 2018-10-01 2019-09-30 02349827 2018-09-30 02349827 core:FurnitureFittings 2018-09-30 02349827 core:LandBuildings core:ShortLeaseholdAssets 2018-09-30 02349827 core:OfficeEquipment 2018-09-30 02349827 2017-10-01 2018-09-30 02349827 2018-09-30 02349827 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2018-09-30 02349827 bus:OrdinaryShareClass2 bus:Non-cumulativeShares 2018-09-30 02349827 bus:OrdinaryShareClass3 bus:Non-cumulativeShares 2018-09-30 02349827 bus:OrdinaryShareClass4 bus:Non-cumulativeShares 2018-09-30 02349827 core:RetainedEarningsAccumulatedLosses 2018-09-30 02349827 core:ShareCapital 2018-09-30 02349827 core:SharePremium 2018-09-30 02349827 core:CurrentFinancialInstruments 2018-09-30 02349827 core:CurrentFinancialInstruments core:WithinOneYear 2018-09-30 02349827 core:Non-currentFinancialInstruments 2018-09-30 02349827 core:Non-currentFinancialInstruments core:AfterOneYear 2018-09-30 02349827 core:FurnitureFittings 2018-09-30 02349827 core:LandBuildings core:ShortLeaseholdAssets 2018-09-30 02349827 core:OfficeEquipment 2018-09-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 02349827

Medezine Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 September 2019

Ian Walker & Co
Heworth House
Melrosegate
Heworth
York
YO31 0RP

 

Medezine Limited

Contents

Balance Sheet

1 to 2

Notes to the Financial Statements

3 to 8

 

Medezine Limited

(Registration number: 02349827)
Balance Sheet as at 30 September 2019

Note

2019
£

2018
£

Fixed assets

 

Tangible assets

4

6,796

9,187

Current assets

 

Stocks

5

54,056

78,715

Debtors

6

200,070

124,786

Cash at bank and in hand

 

428,082

243,949

 

682,208

447,450

Creditors: Amounts falling due within one year

7

(293,372)

(201,668)

Net current assets

 

388,836

245,782

Total assets less current liabilities

 

395,632

254,969

Creditors: Amounts falling due after more than one year

7

(149,924)

-

Net assets

 

245,708

254,969

Capital and reserves

 

Called up share capital

8

103

103

Share premium reserve

7,485

7,485

Profit and loss account

238,120

247,381

Total equity

 

245,708

254,969

For the financial year ending 30 September 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

 

Medezine Limited

(Registration number: 02349827)
Balance Sheet as at 30 September 2019

Approved and authorised by the Board on 5 March 2020 and signed on its behalf by:
 

.........................................
Richard Noble
Director

.........................................
Peter Carroll
Director

 
     
 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2019

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Unit 11 Chambers Way
Thornecliffe Business Park
Chapeltown
Sheffield
S35 2PH

These financial statements were authorised for issue by the Board on 5 March 2020.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2019

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

3 years straight line

Leasehold improvements

over the life of the lease

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2019

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2018 - 4).

 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2019

4

Tangible assets

Short leasehold land and buildings
£

Fixtures and fittings
£

Office equipment
£

Total
£

Cost or valuation

At 1 October 2018

7,565

3,000

2,237

12,802

At 30 September 2019

7,565

3,000

2,237

12,802

Depreciation

At 1 October 2018

378

1,000

2,237

3,615

Charge for the year

1,513

878

-

2,391

At 30 September 2019

1,891

1,878

2,237

6,006

Carrying amount

At 30 September 2019

5,674

1,122

-

6,796

At 30 September 2018

7,187

2,000

-

9,187

Included within the net book value of land and buildings above is £5,674 (2018 - £7,187) in respect of short leasehold land and buildings.
 

5

Stocks

2019
£

2018
£

Other inventories

54,056

78,715

6

Debtors

2019
£

2018
£

Trade debtors

126,150

105,225

Prepayments

20,494

3,404

Other debtors

53,426

16,157

200,070

124,786

 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2019

7

Creditors

Creditors: amounts falling due within one year

Note

2019
£

2018
£

Due within one year

 

Bank loans and overdrafts

9

35,600

-

Trade creditors

 

92,885

98,703

Amounts owed to group undertakings and undertakings in which the company has a participating interest

59,918

59,918

Accruals and deferred income

 

3,897

15,938

Other creditors

 

101,072

27,109

 

293,372

201,668

Creditors: amounts falling due after more than one year

Note

2019
£

2018
£

Due after one year

 

Loans and borrowings

9

149,924

-

8

Share capital

Allotted, called up and fully paid shares

 

2019

2018

 

No.

£

No.

£

Ordinary shares of £1 each

100

100

100

100

Ordinary 'A' shares of £1 each

1

1

1

1

Ordinary 'B' shares of £1 each

1

1

1

1

Ordinary 'C' shares of £1 each

1

1

1

1

 

103

103

103

103

9

Loans and borrowings

2019
£

2018
£

Non-current loans and borrowings

Other borrowings

149,924

-

 

Medezine Limited

Notes to the Financial Statements for the Year Ended 30 September 2019

2019
£

2018
£

Current loans and borrowings

Other borrowings

35,600

-

10

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £56,719 (2018 - £61,600).

11

Parent and ultimate parent undertaking

The company's immediate parent is Medezine Holdings Limited, incorporated in England and Wales.